UAB start-up SunFire Biotechnologies LLC was awarded a grant by the U.S. Department of Defense to continue advancing an assay to support the development of Shigella vaccines.

The Phase II Small Business Innovation Research (SBIR) grant is for approximately $1 million over two years, and will assist SunFire researchers in qualifying and validating the assay so that SunFire can function as a contract research organization for other companies that are developing Shigella vaccines.

Read full article HERE.